Cannabics Pharma Stock Forecast

Sell candidate since Jun 09, 2026

The Cannabics Pharma stock price gained 17.65% on the last trading day (Tuesday, 9th Jun 2026), rising from $0.0002 to $0.0002. During the last trading day the stock fluctuated 100.00% from a day low at $0.0001 to a day high of $0.0002. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks. Volume fell on the last day by -440 thousand shares and in total, 51 shares were bought and sold for approximately $0.0102 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0002 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 44.76% during the next 3 months and, with a 90% probability hold a price between $0.0002 and $0.0007 at the end of this 3-month period.

CNBX Signals & Forecast

There are mixed signals in the stock today. The Cannabics Pharma stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0002. On a fall, the stock will find some support from the short-term average at $0.0002. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, April 27, 2026, and so far it has fallen -50.00%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cannabics Pharma stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0002 and $0.0002. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0.0002 may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0001 between high and low, or 100.00%. For the last week the stock has had daily average volatility of 29.52%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CNBX) For The Upcoming Trading Day Of Wednesday 10th

For the upcoming trading day on Wednesday, 10th we expect Cannabics Pharma to open at $0.0002, and during the day (based on 14 day Average True Range), to move between $0.0002 and $0.0002, which gives a possible trading interval of +/-$0.00006552373557 (+/-39.18%) up or down from last closing price. If Cannabics Pharma takes out the full calculated possible swing range there will be an estimated 39.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0002 (4.00%) than the support at $0.0002 (8.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cannabics Pharma stock A Buy?

Cannabics Pharma holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -3.299 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 10, 2026 - $0.0002 ( 16.67%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk